Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 13.42%8.99B | 25.87%7.93B | 2.47B | 15.57%6.3B | 5.45B |
| Cost of revenue | 15.25%3.96B | 13.44%3.44B | 1.28B | 11.23%3.03B | 2.72B |
| Gross profit | 12.03%5.03B | 37.38%4.49B | 1.2B | 19.90%3.27B | 2.73B |
| Operating expense | 16.23%4.38B | 18.82%3.77B | 1.11B | 42.34%3.17B | 2.23B |
| Operating profit | -9.73%656.54M | 617.46%727.34M | 82.79M | -79.77%101.38M | 501.08M |
| Net non-operating interest income (expenses) | -51.16%-9.54M | -44.03%-6.31M | -2.2M | 23.44%-4.38M | -5.73M |
| Non-operating interest income | 9,886.05%4.29M | -98.49%43K | --21K | -3.98%2.84M | --2.96M |
| Non-operating interest expense | -16.58%5.3M | -12.05%6.36M | --2.22M | -16.81%7.23M | --8.69M |
| Total other finance cost | --8.54M | ---- | ---- | ---- | ---- |
| Net investment income | 55.11%-26.32M | -462.43%-58.65M | -55.53M | 157.06%16.18M | -28.36M |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -198.3M | 0 | 3M | 0 | |
| Income from associates and other participating interests | |||||
| Special income (charges) | 0 | -304K | 3,422.07%52.83M | 1.5M | |
| Less:Other special charges | ---- | ---- | ---- | -3,422.07%-52.83M | ---1.5M |
| Other non-operating income (expenses) | 95.60%-1.05M | -6,274.73%-23.97M | -18.81M | 69.90%-376K | -1.25M |
| Income before tax | -34.01%421.31M | 278.58%638.41M | 5.95M | -63.91%168.63M | 467.25M |
| Income tax | -45.70%82.99M | 56.35%152.84M | -23.28M | -24.86%97.76M | 130.09M |
| Net income | -30.32%338.32M | 585.10%485.57M | 29.23M | -78.98%70.88M | 337.15M |
| Net income continuous operations | -30.32%338.32M | 585.10%485.57M | --29.23M | -78.98%70.88M | --337.15M |
| Noncontrolling interests | -14.4M | 0 | |||
| Net income attributable to the company | -27.36%352.72M | 585.11%485.57M | 29.23M | -78.98%70.87M | 337.15M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.36%352.72M | 585.11%485.57M | 29.23M | -78.98%70.87M | 337.15M |
| Gross dividend payment | |||||
| Basic earnings per share | -37.73%7.84 | 583.68%12.59 | 0.6763 | -76.39%1.8415 | 7.8007 |
| Diluted earnings per share | -40.49%7.48 | 582.59%12.57 | 0.6763 | -76.39%1.8415 | 7.8007 |
| Dividend per share | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |